ArticleThe lancet. Diabetes & endocrinology2022

Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence - Authors' reply.

Maria Fleseriu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.